HEPA
Hepion Pharmaceuticals
HEPA
HEPA
Delisted
HEPA was delisted on the 12th of May, 2025.
4 hedge funds and large institutions have $380K invested in Hepion Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
4
Holders Change
–
Holders Change %
0%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$41K |
| 2 |
Morgan Stanley
New York
|
-$34K |
| 3 |
JPMorgan Chase & Co
New York
|
-$33K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$26K |
| 5 |
PFS
Prospera Financial Services
Dallas,
Texas
|
-$26K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
1
Vanguard Group
Malvern,
Pennsylvania
| $183K | – | – | – |
|
2
HighTower Advisors
Chicago,
Illinois
| $73K | – | – | – |
|
3
Geode Capital Management
Boston,
Massachusetts
| $35K | – | – | – |
|
4
Barclays
London,
United Kingdom
| $31K | – | – | – |
|
|
5
JPMorgan Chase & Co
New York
| $14K | -$33K | – | – |
|
|
6
Northern Trust
Chicago,
Illinois
| $11K | -$26K | – | – |
|
|
CS
7
Credit Suisse
Zurich,
Switzerland
| $11K | -$41K | – | – |
|
|
VF
8
Virtu Financial
New York
| $6K | – | – | – |
|
|
9
Morgan Stanley
New York
| $5K | -$34K | – | – |
|
10
UBS Group
Zurich,
Switzerland
| $5K | – | – | – |
|
11
BlackRock
New York
| $4K | -$8K | – | – |
|
|
LTFS
12
Ladenburg Thalmann Financial Services
Miami,
Florida
| $2K | – | – | – |
|
|
PFS
13
Prospera Financial Services
Dallas,
Texas
| – | -$26K | – | – |
|